Another study also showed that miR-598 is a therapeutic target in NSCLC cells and that regulating the expression of ZEB2 can have an effect on the expression of miR-598, and that miR-598 may inhibit the growth of NSCLC by directly targeting ZEB2 [44]. This evidence concerns the gene ZEB2 and non-small cell lung carcinoma.